FRANKLIN, Tenn.--(BUSINESS WIRE)--BioMimetic Therapeutics, Inc. (Nasdaq: BMTI) announced today the pricing of an offering of 2,829,000 shares of its common stock at a price of $17.15 per share. Of the shares of common stock being offered, 2,123,575 are being offered by the Company, with the remaining 705,425 shares of common stock being sold by selling stockholders identified in the prospectus. BioMimetic Therapeutics, Inc. will not receive any proceeds from the sale by the selling stockholders.
